Here are a few of the most interesting Sarepta Therapeutics statistics and facts I was able to dig up. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Please note that some of these numbers are easier to find than others. A few of these Sarepta Therapeutics stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%
Sarepta Therapeutics Facts
- Website: www.sarepta.com
- Year Founded: 1980 (as Antivirals Inc)
- Headquarters: Cambridge, MA
- CEO: Douglas Ingram
Sarepta Therapeutics Statistics
Number of Sarepta Therapeutics employees:
Last updated 1/1/20
Sarepta Therapeutics annual revenue:
- 2019: $380 million
- 2018: $301 million
- 2017: $154 million
- 2016: $5 million
- 2015: $1 million
Sarepta Therapeutics annual net income:
- 2019: $715 million net loss
- 2018: $361 million net loss
- 2017: $50 million net loss
- 2016: $267 million net loss
- 2015: $220 million net loss